Indicator Testing Culture Media was the largest of Neogen Corp’s 9 reported lines in fiscal 2026, at $332.70M — 39% of $852.20M.
| Product and Service | FY 2016 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Indicator Testing Culture Media | — | $322.00M | $312.20M | $332.70M | |||||
| Product Revenues | — | — | — | — | |||||
| Indicator Testing, Culture Media & Other | $267.18M | — | — | — | |||||
| Bacterial General Sanitation | $134.93M | $171.20M | $164.80M | $175.40M | |||||
| Bacterial &Amp; General Sanitation | — | — | — | — | |||||
| Rodenticides, Insecticides Disinfectants | $87.42M | $88.70M | $88.10M | $68.90M | |||||
| Rodenticides, Insecticides &Amp; Disinfectants | — | — | — | — | |||||
| Natural Toxins Allergens | $82.57M | $82.20M | $77.00M | $77.50M | |||||
| Genomics Services | $79.06M | $70.80M | $89.20M | $92.20M | |||||
| Natural Toxins, Allergens Drug Residues | — | — | — | — | |||||
| Natural Toxins, Allergens &Amp; Drug Residues | — | — | — | — | |||||
| Veterinary Instruments Disposables | $63.84M | $65.80M | $61.50M | $56.90M | |||||
| Veterinary Instruments &Amp; Disposables | — | — | — | — | |||||
| Culture Media Other | — | — | — | — | |||||
| Culture Media &Amp; Other | — | — | — | — | |||||
| Service Revenues | — | — | — | — | |||||
| Animal Care Other | $39.07M | $37.00M | $34.70M | $29.30M | |||||
| Animal Care &Amp; Other | — | — | — | — | |||||
| Other | — | $12.60M | $13.70M | $12.70M | |||||
| Life Sciences | $6.25M | $6.50M | $6.50M | $6.60M | |||||
| Total | $760.33M | $856.80M | $847.70M | $852.20M |
In fiscal 2026, which ended May 31, 2026, the 9 revenue lines Neogen Corp reported in this breakdown added up to $852.20M. That was up 0.5% from $847.70M in fiscal 2025. Indicator Testing Culture Media was the largest revenue line, at $332.70M or 39.0% of the total, followed by Bacterial General Sanitation ($175.40M, 20.6%) and Genomics Services ($92.20M, 10.8%). Together, the two largest revenue lines made up 59.6% of this total.
Compared with fiscal 2025, Indicator Testing Culture Media grew the fastest, rising 6.6% to $332.70M. Rodenticides, Insecticides Disinfectants fell the most, down 21.8% to $68.90M.
Indicator Testing Culture Media (fiscal 2024) and Other (fiscal 2024) were first reported as separate revenue lines during this period. The table also keeps 11 revenue lines that Neogen Corp no longer reports, so earlier years can still be read on their original basis; use "Show 11 discontinued" beneath the table to see them. This breakdown covers 9 fiscal years between 2016 and 2026, as reported in Neogen Corp's annual filings.
Food Safety was the largest of Neogen Corp’s 2 reported lines in fiscal 2026, at $508.10M — 84% of $606.30M.
| Segment | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Food Safety | $267.18M | $493.20M | $477.00M | $508.10M | |||||||||||||
| Animal Safety | $126.49M | $125.70M | $122.80M | $98.20M | |||||||||||||
| Total | $393.67M | $618.90M | $599.80M | $606.30M |
In fiscal 2026, which ended May 31, 2026, the 2 segments Neogen Corp reported in this breakdown added up to $606.30M. That is less than the $870.40M in its breakdown by region, so these segments do not account for all of its revenue that year. Food Safety was the largest segment, at $508.10M or 83.8% of the total, followed by Animal Safety ($98.20M, 16.2%).
Compared with fiscal 2025, Food Safety grew the fastest, rising 6.5% to $508.10M. Animal Safety fell the most, down 20.0% to $98.20M.
This breakdown covers every fiscal year from 2010 to 2026, as reported in Neogen Corp's annual filings.
International was the largest of Neogen Corp’s 2 reported lines in fiscal 2026, at $445.30M — 51% of $870.40M.
| Geography | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|
| Domestic | $424.01M | $465.20M | $446.00M | $425.10M | ||
| International | $398.44M | $459.00M | $448.70M | $445.30M | ||
| Total | $822.45M | $924.20M | $894.70M | $870.40M |
In fiscal 2026, which ended May 31, 2026, the 2 regions Neogen Corp reported in this breakdown added up to $870.40M. That was down 2.7% from $894.70M in fiscal 2025. International was the largest region, at $445.30M or 51.2% of the total, followed by Domestic ($425.10M, 48.8%).
Compared with fiscal 2025, every sizeable region reported in both years shrank. International held up best, down 0.8% to $445.30M, while Domestic fell the most, down 4.7% to $425.10M. Over fiscal 2023 to 2026, revenue across these regions went from $822.45M to $870.40M, a compound annual growth rate of 1.9%. International's share of the total rose from 48.4% to 51.2% over the same years.
This breakdown covers every fiscal year from 2021 to 2026, as reported in Neogen Corp's annual filings.
Neogen Corp (NEOG) breaks its revenue down by revenue line, segment and region. In fiscal 2026, its largest revenue line was Indicator Testing Culture Media, with $332.70M or 39.0% of the total, followed by Bacterial General Sanitation at $175.40M (20.6%).
Indicator Testing Culture Media was Neogen Corp's largest revenue line in fiscal 2026, with $332.70M in revenue, 39.0% of the $852.20M reported across its 9 revenue lines.
Food Safety was Neogen Corp's largest segment in fiscal 2026, with $508.10M in revenue, 83.8% of the $606.30M reported across its 2 segments.
International was Neogen Corp's largest region in fiscal 2026, with $445.30M in revenue, 51.2% of the $870.40M reported across its 2 regions.
Of the Neogen Corp revenue lines reported in both fiscal 2025 and fiscal 2026, and making up at least 2% of the total, Indicator Testing Culture Media grew the fastest, rising 6.6% from $312.20M to $332.70M.
Every figure is taken from Neogen Corp's annual financial filings and shown as reported: each line keeps the name the company gives it, years follow its own fiscal calendar, and lines it has stopped reporting stay in the table for the years they were reported.
The breakdown by revenue line covers fiscal 2016 to 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.